logo
Self-Management Asthma App Boosts Symptom Control in Adults

Self-Management Asthma App Boosts Symptom Control in Adults

Medscape3 days ago
TOPLINE:
In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among African American participants.
METHODOLOGY:
Researchers conducted a randomized trial to evaluate the impact of a DASM program on symptom control among adults with asthma.
A total of 899 participants (mean age, 36.6 years; 71.1% women; approximately 61.3% with uncontrolled asthma) were recruited via email between October 2020 and November 2021 to receive either the DASM program (n = 450) or usual care (n = 449).
All the enrolled participants installed a custom smartphone app and utilized wearable devices during the trial. The DASM group received a full-featured self-management version with symptom tracking and alerts, whereas the usual care group received a limited version with only the asthma control test and collection of patient-reported outcomes.
The primary outcomes included the 12-month change from baseline in asthma control test scores (scores ≤ 19 indicated uncontrolled asthma), and secondary outcomes included participants' counts of symptom logs and patient-reported outcomes.
TAKEAWAY:
Among participants with uncontrolled asthma, the DASM intervention improved mean asthma control test scores by 4.6 points at 12 months compared with a 1.8-point improvement with usual care (adjusted difference, 2.8 points; P < .001).
The treatment effect varied by race, with between-group differences in asthma control test scores showing improvements of 1.0 point (P = .26) in African American participants and 3.3 points (P < .001) in non-African American participants.
Symptom logging rates were comparable across insurance and ethnicity subgroups, with no significant differences observed. However, African American participants logged symptoms less frequently than non-African American participants.
Patient-reported outcomes — self-reported medication adherence, readiness to change self-management behaviors, confidence in the ability to manage one's health, and asthma-related work productivity impairment — also favored the DASM intervention over usual care (P ≤ .001 for all).
IN PRACTICE:
'Findings reveal an opportunity to adapt the DASM program for more consistent effects throughout diverse populations. Future research is needed — quantitative and qualitative — to elucidate causes of differences in outcomes,' the authors wrote.
SOURCE:
The study was led by Jordan Silberman, MD, PhD, Office of Medical Policy and Technology Assessment, Elevance Health, Palo Alto, California. It was published online on July 17, 2025, in JAMA Network Open.
LIMITATIONS:
The study was limited by the requirement for iPhone ownership, exclusion of uninsured participants, lack of blinding, and potential for biased missingness despite robust sensitivity analyses.
DISCLOSURES:
This study was funded by Elevance Health, Inc. (formerly Anthem Inc.), with support from Apple Inc. Three authors declared receiving financial support from Apple or grants from Elevance Health. One author reported receiving stock from Elevance Health. Few other authors reported receiving financial aid from the University of California and pharmaceutical companies, including Pfizer, AstraZeneca, and Eli Lilly and Company.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

States sue Trump administration over access to care for transgender youths
States sue Trump administration over access to care for transgender youths

Washington Post

time29 minutes ago

  • Washington Post

States sue Trump administration over access to care for transgender youths

A coalition of more than a dozen states sued the Trump administration on Friday over health care for transgender young people, claiming the White House has 'relentlessly, cruelly, and unlawfully targeted transgender individuals' since President Donald Trump took office. The lawsuit, filed in federal court in Massachusetts, seeks to have part of one executive order issued in January declared unconstitutional. The order targets gender-affirming care provided to people under the age of 19, such as puberty blockers, hormone therapy and surgical procedures, which it refers to as 'mutilation.' The lawsuit also asks the court to declare unlawful the Justice Department's targeting of providers of gender-affirming care. The section of the order that is being challenged directs the Justice Department to use laws such as the Food, Drug and Cosmetic Act, those against female genital mutilation, and child custody legislation to carry out the administration's aims. 'It is the policy of the United States that it will not fund, sponsor, promote, assist, or support the so-called 'transition' of a child from one sex to another,' Trump's order says, calling the treatments 'a stain on our Nation's history.' The states of Massachusetts, California, New York, Connecticut, Illinois, Delaware, Hawaii, Maine, Maryland, Michigan, Nevada, New Jersey, New Mexico, Rhode Island and Wisconsin, as well as the District of Columbia and Josh Shapiro in his capacity as Pennsylvania governor, filed suit. The lawsuit, filed against Trump, the Justice Department and Attorney General Pam Bondi, argues that the executive order conflicts with states' remit to regulate and police medicine and violates the 10th Amendment, which protects states' powers, and is in conflict with many state antidiscrimination laws. Nearly every major medical association endorses the availability of gender-affirming care for transgender young people, citing reductions in depression, substance abuse and suicide attempts. 'Empirical evidence has demonstrated that trans and nonbinary gender identities are normal variations of human identity and expression,' the American Medical Association has said. But the issue, and others related to transgender people, has animated conservatives. Trump has said he wants the 'official policy of the United States' to be that there are only two genders and has referred to being transgender as a 'falsehood.' The administration has moved to ban transgender service members from the military, relocate incarcerated transgender women into men's prisons and bar transgender people from using restrooms that align with their gender identity in federal buildings, among a slew of anti-trans measures, many of which have been challenged in court. After the January order, the lawsuit says, the Justice Department began 'intimidating providers into ceasing care through threats of civil and criminal prosecution.' 'These threats have no basis in law,' the complaint says. 'No federal law prohibits, much less criminalizes, the provision or receipt of gender-affirming care for transgender adolescents.' Puberty blockers temporarily inhibit sex hormones, such as estrogen and testosterone, and other hormone therapies introduce them to the body. Gender-affirming surgeries, such as breast reductions for transgender men, are rarely performed on minors. White House spokesperson Taylor Rogers said in an email that 'everyday Americans resoundingly support' the administration's actions. 'The President has the lawful authority to protect America's vulnerable children through executive action, and the Administration looks forward to ultimate victory on this issue,' she added. In June, the Supreme Court upheld a ban on gender-affirming care for minors in Tennessee.

The Manhattan shooter had a previous arrest and 2 psychiatric holds, sources say. How was he able to own a gun?
The Manhattan shooter had a previous arrest and 2 psychiatric holds, sources say. How was he able to own a gun?

CNN

time29 minutes ago

  • CNN

The Manhattan shooter had a previous arrest and 2 psychiatric holds, sources say. How was he able to own a gun?

Crime Gun violence Gun control Mental healthFacebookTweetLink Follow New York City's deadliest shooting in 25 years – in a state with some of the toughest gun laws in the nation – is raising questions about how a gunman with a history of mental health issues was able to obtain multiple firearms and drive undetected across several states to carry out the attack. The gunman who walked into a Midtown Manhattan office building on Monday, M4 assault-style rifle in hand, and sprayed it with gunfire, had a license to carry a concealed weapon in his home state of Nevada, officials said. He also had been placed on psychiatric hold in 2022 and 2024, law enforcement sources told CNN. But that may not have necessarily prohibited him from obtaining his license in 2022 or buying firearms – depending on the circumstances of the holds, according to gun law experts. Shane Devon Tamura, 27, of Las Vegas, killed four people at the 345 Park Avenue office building and injured another before he died by suicide, police said. While public health experts continue to stress that the vast majority of people experiencing mental health challenges are not violent, questions remain about the details of Tamura's psychiatric holds and if they would have shown up in a background check. The case underscores the wide gap in sharing mental health data with the federal government – an issue that can be attributed to inadequate funding to manage or require the data, as well as privacy issues, according to Thomas Chittum, former associate deputy director of the Bureau of Alcohol, Tobacco, Firearms and Explosives. Tamura had 'a documented mental health history,' according to New York Police Department Commissioner Jessica Tisch, and a previous run-in with law enforcement. Tamura was arrested and charged with misdemeanor trespassing in 2023 in Clark County, Nevada, after he refused to leave a Las Vegas casino after attempting to cash out about $5,000, according to a police incident report. A court database suggests a district attorney declined to pursue the case, meaning the incident wouldn't have prevented him from obtaining a gun. The case also throws private gun sales under the microscope. The AR-15 style weapon used in the shooting was legally purchased last year by the gunman's supervisor at the Vegas casino where he worked, two law enforcement officials told CNN. The supervisor then assembled it and sold it to Tamura for $1,400, the officials said, citing an interview with the supervisor who is cooperating with authorities. It's not yet clear whether the private sale between Tamura and the supervisor involved a background check. But the supervisor, who has not been named by authorities, could face legal jeopardy if the investigation reveals the firearm transfer took place in Nevada and the private sale didn't follow a state law requiring background checks for private sales, according to Warren Eller, gun violence expert and associate professor at John Jay College of Criminal Justice. As police work to uncover a motive behind the shooting, investigators are digging into Tamura's history and examining are how he obtained multiple firearms and made his way from Las Vegas to New York City with the assault rifle. A search of the gunman's car turned up a host of items, including additional ammunition, another loaded weapon, headphones potentially used for target practice, two cell phones, the antidepressant Zoloft and cannabis, a law enforcement source told CNN. A note found in the gunman's pocket claimed he had CTE, a disease linked to head trauma, one that's often associated with football players, a source told CNN. New York City's chief medical examiner's office will test Tamura's remains for CTE, an office spokesperson told CNN Tuesday. The only way to diagnose the disease is through an autopsy of the brain. As for the psychiatric holds, it's difficult to say without knowing the details whether they would have shown up in a background check or prevented Tamura from purchasing weapons, experts say. 'If you were on a 48-hour hold, if you were released at the end of that, it would not affect your ability to possess firearms under federal law,' Chittum said. Most states barely touch on the area of mental health when a person applies for a gun license due to concerns over privacy issues and stigmatizing people who have mental health issues, according to Eller. One concern, for example, is soldiers who struggle with post-traumatic stress disorder, or PTSD, might be reluctant to seek help because they fear their treatment history would deprive them of possessing firearms. 'Between the lack of funding to make sure the background check system is effective for those problems and the legal hang ups with advocacy groups who will challenge this, that's a long road ahead,' Eller said. There's a concerted effort by veterans' groups and advocacy organizations like the American Civil Liberties Union to fight against the sharing of mental health records with the National Crime Information Center and local law enforcement, which most states rely on for background checks, according to Eller. 'Groups have been combating that because simply being mentally ill doesn't mean you're mentally incompetent, nor does it mean you're a danger,' he added. However, in cases where a person was declared incompetent by a court, faced a restraining order, involuntarily committed or deemed a danger to themselves or others due to a mental illness, the federal government restricts firearm ownership and states largely follow federal law with some variations, according to Chittum. 'Even when we have someone who has a mental health issue that prohibits them under the law, the next question is whether the background check identifies that. Historically, mental health records have been some of the hardest for FBI to obtain when doing background checks,' Chittum said, adding there have been efforts to improve the availability of those records in some legislation. As New York homicide detectives work to piece together a timeline of events leading up to the deadly Manhattan attack, the way Tamura obtained the high-powered M4 rifle from an associate and whether Nevada's background check laws were violated will likely come under scrutiny. In Nevada, the private sale of a firearm between two parties requires a federal background check before the transfer is complete. Both individuals must go to a federally licensed firearm dealer, which conducts the background check on their behalf. There are limited exceptions, including firearm transfers between immediate family members, which do not require this process. If the private sale between Tamura and the supervisor did abide by the law and the facts can't prove the supervisor had any knowledge of possible disqualifiers in Tamura's history, including intended use of the firearm, then the seller likely won't be prosecuted, according to Eller and Chittum. Federal law doesn't impose any obligation on private gun sellers to identify the buyer, conduct a background check or keep any record of the sale, Chittum said. The Nevada law enforcing background checks for private sales was implemented in January 2020, closing the so-called 'gun show loophole' that gun safety advocates have long criticized as a means for bypassing records checks that can flag past criminal history. Most states conduct background checks through federally licensed dealers relying on the FBI's National Instant Criminal Background Check System (NICS), while some states like Nevada have a designated 'point of contact' system that offers access to state criminal history records. Under federal law, an unlicensed person buying a firearm directly from a gun dealer must also undergo a background check, however, those who already have a concealed carry permit – like Tamura had – may be exempt because they would have already undergone a background check to get the permit. Hours after the shooting in Manhattan, Las Vegas Police Crimestoppers received a tip from a licensed firearms dealer saying he remembered Tamura sought to buy an aftermarket trigger assembly for an M4 rifle at a Las Vegas gun show in June, a senior law enforcement official told CNN. Tamura returned the trigger assembly the next day, saying he needed the money back to buy 500 rounds of .223 ammunition – the same kind of ammunition used in the New York shooting, according to the official. The gun dealer told police Tamura came back the next day with additional funds and re-purchased the trigger assembly, the official said. Tamura's case calls attention to the 'gray area' in the federal regulation and enforcement of private sales that exists when people buy firearms for cash in a private sale, according to Eller. Because a concealed carry permit would exempt an individual for five years from a background check when buying a firearm from a licensed dealer, it creates a 'nuanced area' where a person could obtain a license to carry and then subsequently be convicted or have a mental health prohibitor and might still be able to use their card to purchase a firearm and avoid the background check, Chittum said. Some states recognize this issue and routinely run background checks on licensed holders to determine if their license is still valid, Chittum said. Red flag laws, including the one in Nevada, aim to keep guns out of the hands of those who pose a threat to themselves or others. But such laws are only effective if the individual demonstrated warning signs so that others can alert law enforcement and initiate the process of revoking the person's firearm, Chittum said. It's not clear if Tamura demonstrated any warning signs that would trigger the state's red flag law. The style of weapon Tamura used to slaughter four people has commonly been seen in some of the nation's deadliest mass shootings and has prompted renewed calls by progressive lawmakers for increased regulation. 'In the State of New York, you cannot buy one of these,' Gov. Kathy Hochul told CNN on Tuesday, criticizing what she said were 'much looser laws in the State of Nevada than we have here.' Hochul called on federal lawmakers to pass a national assault weapon ban that would limit access to high-powered guns like the AR-15 style rifle used in Monday's massacre and slammed GOP counterparts whom she accused of being 'intimidated by the gun lobby.' 'We need a national awakening here, people need to be talked about this once again and it shouldn't just happen in the wake of a tragedy like this,' said Hochul. CNN's Mark Morales contributed to this report.

Justin Timberlake has Lyme disease. A doctor explains what it is
Justin Timberlake has Lyme disease. A doctor explains what it is

Yahoo

timean hour ago

  • Yahoo

Justin Timberlake has Lyme disease. A doctor explains what it is

As pop star Justin Timberlake concluded his world tour earlier this week, the 'SexyBack' singer shared on Thursday in a social media post that he has been grappling with health issues and a diagnosis of Lyme disease. Timberlake did not disclose which stage of Lyme disease he is experiencing in his Instagram post relaying his diagnosis, but the singer wrote, 'At least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness.' His ordeal, like that of Bella Hadid and other celebrities before him, brings up many questions. What exactly is Lyme disease, and how is it contracted and spread? How is the illness diagnosed and treated? What does it mean when someone has 'chronic Lyme'? Is there a vaccine for Lyme disease? To help us with these questions, I spoke with CNN wellness expert Dr. Leana Wen, an emergency physician and professor of health policy and management at the George Washington University Milken Institute School of Public Health. She previously served as Baltimore's health commissioner. CNN: Can you start by explaining what Lyme disease is? Dr. Leana Wen: Lyme disease is a bacterial infection. The bacterium Borrelia burgdorferi is the most common cause. In rare cases, Borrelia mayonii may cause the illness also. In the United States, Lyme is the most common disease spread by vectors, which are animals such as mosquitoes and ticks that spread infections. Lyme disease is transmitted through the bite of a particular tick, the black-legged tick (Ixodes scapularis and Ixodes pacificus). There are three stages of Lyme disease. The first stage is early localized disease that begins within a day to four weeks after the tick bite. People develop flu-like symptoms such as headache, muscle aches and fatigue. Some develop a characteristic 'bull's-eye' rash known as erythema migrans. The second stage occurs three to 12 weeks after the initial infection. This is the 'early disseminated' stage in which people have more widespread symptoms. They can include dizziness, chest pain, palpitations, arthritis and facial nerve paralysis. The third stage is 'late disseminated' disease, which can occur months after infection. Here, again, there is a constellation of symptoms. They include ongoing joint pain, fatigue, depression, palpitations, and other neurological, rheumatological and cardiac involvement. CNN: How is Lyme disease treated, and why is it important to get prompt treatment? Wen: Early diagnosis and prompt treatment can prevent complications and the progression to the next stages of disease. The standard treatment is antibiotic therapy. Most people are cured after taking oral antibiotics for 10 to 14 days. Preventive therapy is common, too. If someone has been bitten by a black-legged tick, also known as a deer tick , in an area of the country known to have Lyme, they could take one dose of the antibiotic doxycycline to prevent Lyme infection. This step should be done within 72 hours of the tick bite. It's important to carefully remove the tick if it's still attached. Take a picture and bring it with you to the doctor's appointment, or send the picture to your provider if you're having a telemedicine visit. CNN: Is there a blood test one could take to see whether they have Lyme disease? Wen: Yes, though there are several limitations. The most common tests are antibody tests, which detect antibodies the body makes in response to infection. These tests probably don't turn positive until several weeks after infection, so if someone just got infected and took the test, it will be negative even if the person has Lyme. In addition, the antibodies could persist in the blood for months or even years, but their presence alone does not signify that Lyme disease is the cause of all the symptoms a person may have. False positives also can occur, with some other tickborne diseases and autoimmune illnesses triggering a positive result in the absence of Lyme disease. CNN: Then how is Lyme disease diagnosed? Wen: Typically, it's diagnosed through a careful symptom documentation and an exposure history. Physical signs, such as the characteristic rash, enlarged lymph nodes or joint swelling, can aid in the diagnosis, as well. Blood testing can help but has limitations, as I mentioned earlier. The provider often presumptively treats with antibiotics based on the clinical history. CNN: What does it mean when someone has 'chronic Lyme'? Wen: There is a condition called post-treatment Lyme disease syndrome, or PTLDS. This refers to people who have had Lyme disease but, six months or longer after completing treatment, still have persistent symptoms. These symptoms can include fogginess, difficulty thinking, ongoing fatigue, and nerve and joint pain. It's not known why some people develop PTLDS. There are several hypotheses, including a persistent infection or autoimmune response. The symptoms of PTLDS can be treated, but there is no proven cure. The term 'chronic Lyme disease' includes people who have PTLDS. It is sometimes also used to describe symptoms in people who have not been diagnosed with Lyme disease. According to the National Institute of Allergy and Infectious Diseases, 'because of the confusion in how the term (chronic Lyme disease) is employed, and the lack of a clearly defined clinical definition, many experts in this field do not support its use.' In my experience as a physician and patient advocate, I have met many people who believe they have this condition and are really suffering. Many are debilitated as a result and unable to function as they previously did. Just like long Covid and other similar conditions, there is much that we do not understand about this condition. Far more research needs to be done in order to alleviate the very real agony and distress that these patients are experiencing. CNN: Is there a vaccine for Lyme disease? Wen: There are several vaccines against Lyme disease for dogs. For humans, there are some late-stage clinical trials that are ongoing, including one by Valneva and Pfizer that could be submitted for regulatory approval by 2025. CNN: What are ways to avoid contracting Lyme? Wen: Without a vaccine, the best way to prevent Lyme disease is to prevent tick bites. If you are going to areas where ticks known to carry Lyme are found, wear long-sleeved shirts and pants. Use insect repellent that contains DEET. Once you return indoors, examine yourself — and children and pets — for ticks. Remove the tick if found, and immediately contact your primary care provider to ask about preventive antibody treatment. And stay alert for symptoms, since early antibiotic therapy is crucial to prevent longer-term consequences. Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store